/
A Plasmid based Reference/Control Strategy for Targeted NGS in Oncology A Plasmid based Reference/Control Strategy for Targeted NGS in Oncology

A Plasmid based Reference/Control Strategy for Targeted NGS in Oncology - PowerPoint Presentation

bikersphobia
bikersphobia . @bikersphobia
Follow
345 views
Uploaded On 2020-06-23

A Plasmid based Reference/Control Strategy for Targeted NGS in Oncology - PPT Presentation

Why Plasmids Addition of alien barcode permits identification in a mixture Multiple plasmids can be mixed into the background of a human reference genome providing controls for multiple targets and sequence variants missense in ID: 784838

assay reference plasmids control reference assay control plasmids controls targeted dna normal ratios genomic standards spike moi frequency akt1

Share:

Link:

Embed:

Download Presentation from below link

Download The PPT/PDF document "A Plasmid based Reference/Control Strate..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

A Plasmid based Reference/Control Strategy for Targeted NGS in Oncology

Why Plasmids?:

Addition of alien bar-code permits identification in a mixture

Multiple plasmids can be mixed into the background of a human reference genome providing controls for multiple targets and sequence variants (missense, in/

dels

,

homopolymers

etc.)

Rapid design, manufacture and sequence verification

Possible disadvantage, does not represent a genome (i.e. large DNA fragments), therefore does it perform similarly to a human genomic DNA sample in the targeted assay?

Uses:

Reference Standards

Spike in assay positive controls

Slide2

*

MOI

Alien Barcode (6bp)

~1000bp

*

MOI at highest mutation frequency per gene

Control Plasmids for Reference

Standards

*

Cloning

Verify by Sanger

Precise quantification

Blend

with normal at pre-defined

ratios

2

Access Specificity, Sensitivity, and Limit of detection during assay development

Internal controls to monitor assay performance run by run

Reference materials for comparing results of assays performed by different platforms, operators, times, and sites

Applicable for all kinds of assays - amplicon targeted seq, exome capture, Haloplex, HRMC (PCR), Pyroseq, Sanger seq, …

Slide3

Control Plasmid Spike-in CEPH (CPSC)

*

BRAF

V600E

*

KRAS

G12V

PIK3CA

H1047R

*

AKT1

F35L

*

MET

Y1253D

*

Mix with normal genomic DNA

(mutant vs normal) at various copy number ratios

1:5

1:10

1:20

1:40

1:80

20% 10% 5% 2.5% 1.25%

3

Slide4

Assay Detects

M

utations at 5% Frequency4

Miseq/TSCAPGM/Ampliseq

Observed Frequency

20%CPSC10%CPSC5%CPSC2.5%CPSC1.25%CPSC20%CPSC10%CPSC5%CPSC2.5%CPSC

1.25%CPSCCEPHCEPH

Slide5

List of MOIs in Control Plasmids

AKT1

_p.E49KAKT1_p.E17KAKT2_p.V90LAKT3_p.Q124LAPC_p.R1450*ARHGAP5_p.E622K ATM_p.D1853NATR_p.I1264fs*24BRAF_p.V600ECTNNB1_p.T41AERCC1_p.A96EFBXW7_p.R465HFGFR3_p.S249CGABRA6_p.V255LGABRG2_p.Y452CGNAQ_p.Q209LGNAS_p.R201CKRAS_p.G12VMET_p.Y1253DMLH1_p.V384DMSH2_p.G751fs*12MTOR_p.L888FNF1_p.R1362*NRAS_p.Q61RPARP1

_p.G913fs*4PARP2_p.D133APDGFRA_p.D842VPIK3CA_p.E545KPIK3CA_p.H1047RPTEN_p.R130*PTPN11_p.E76KRAD51_p.Q145*RB1_p.R320*NBN_p.P748SDNMT3A_R882CEGFR_E746_A750delEGFR_L858REGFR_T790MEZH2_Y646FFLT3_D835YIDH1_R132CERBB2_M774_A775insAYVM

IDH2_R140QIDH2_R172KJAK2_V617FKIT_D816VMPL_W515LMYD88_L265PNPM1_W288fs*12RET_M918TTP53_R273HTP53_R248QTP53_R175H……

5

Challenge MOIs (in homopolymer region)APC_T1556fs*, (insA in AAAAAACT)PTEN_ K267fs*9 , (delA in AAAAAAGG)NF1_M799fs*22 , (delA in CCAAAA)